STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more
And so, another working week will soon draw to a close. Not a moment too…
Category: Pharmaceuticals
Gilead sours on the ‘don’t eat me’ business
Want to stay on top of the science and politics driving biotech today? Sign up to get…
New pharma CEOs in the hot seat
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: As Medicare drug pricing negotiations begin, AstraZeneca stays mum on government’s offer
LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor…
The GLP-1 panic is alive and well
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: House panel passes key PBM reform for sliver of commercial market
WASHINGTON — A House panel passed a bipartisan bill to ban drug middlemen from charging…
STAT+: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV
The Colombian government has taken a significant step toward issuing a compulsory license for a…
Opinion: Aduhelm was a mess — and it could happen again
Last week, Biogen announced it will cease both the study and sale of Aduhelm, its…
STAT+: A sweeping new lawsuit asks: Are employers liable if they overpay for drugs?
Johnson & Johnson faces a consequential new class action lawsuit — not in its role…
Regeneron is interested in obesity treatments that combat muscle loss
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Novo Holdings to purchase drug manufacturer Catalent for $16.5 billion, a deal that could expand Wegovy production
LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent…
What makes a drug a blockbuster — or a cautionary tale?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Listen: Vertex’s polarizing data, Aduhelm’s adieu, & an FDA icon
What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a…
Medicare drug price negotiation’s day in court
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Novavax is on thin ice, and the latest update isn’t exactly encouraging
Want to stay on top of the science and politics driving biotech today? Sign up to…
STAT+: Biden administration makes opening offers in Medicare drug price negotiations
WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its…
STAT+: Judge skeptical of arguments against Medicare drug price negotiation
WILMINGTON, Del. — Today was the first time that a federal judge asked questions in-person…
Pfizer’s reset year starts with a little profit
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Experts critique flawed system for monitoring drugs’ side effects in wake of asthma drug report
After a drug enters the market, it’s up to Food and Drug Administration regulators to…
STAT+: As supply crunch starts to ease, Novo Nordisk to offer more doses of obesity drug Wegovy to U.S. patients
LONDON — Novo Nordisk said Wednesday that it had started to increase the availability of…
How an immunological Trojan horse could treat disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next
WASHINGTON — It’s the end of an era for the Food and Drug Administration’s longtime…
STAT+: European regulators tout their accomplishments against pharma’s anticompetitive practices
European antitrust regulators want you to know that fighting crime in the pharmaceutical industry pays….
23andMe breach targeted Chinese, Jewish populations
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Eli Lilly overtakes Tesla in market value
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Generic group sues Illinois over a price-gouging law with ‘draconian regulations’
The trade group for generic drug companies in the U.S. has filed a lawsuit alleging…
Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says
WASHINGTON — Sen. Bernie Sanders on Thursday jabbed the CEO of Merck for telling congressional…
STAT+: CVS wants to become a medical powerhouse. Will long lines and understaffing hold it back?
CVS Health is perhaps best known for two things. First, there are the comically long…
Bernie Sanders’ showdown with pharma CEOs is coming to a head
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages
WASHINGTON — A key Senate committee is proposing that Medicare pay bonuses to hospitals that…
Another step toward new drugs for Parkinson’s
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: A PBM in Africa flips the industry’s script in a bid to make people healthier
WASHINGTON — For an app that helps pharmacies in Africa manage their medicines, the term…
STAT+: When it comes to policing pharma, the FTC says it’s on ‘an incredible winning streak’
Over the past two years, the U.S. Federal Trade Commission has attempted to crack down…
Lilly’s gene therapy restores hearing in an 11-year-old, paving way for more treatment
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Want to stay on top of the science and politics driving biotech today? Sign up to get…
White House pharmacy under the microscope
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
STAT+: Pharma’s attack on Medicare drug price negotiation might benefit Biden
WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program…
The White House has a pharmacy — and it’s been a mess, a new investigation found
There’s a pharmacy in the White House — or, at least, there’s a sign that…
STAT+: Sanofi scoops up U.S. biotech Inhibrx for up to $2.2 billion as it seeks to bolster pipeline
LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday…
Investigators fault Lilly plant for manufacturing issues
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: STAT+: Some countries are moving to digital prescription drug information for patients. The U.S. shouldn’t follow suit
Getting a new prescription can be overwhelming: medication schedules, foods to eat or avoid, interactions…
STAT+: In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property
In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer…
STAT+: FDA scolds Novartis over a misleading TV ad for a breast cancer treatment
The U.S. Food and Drug Administration scolded Novartis for making false and misleading statements about…
The Senate health committee looks into its first subpoena in 40 years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate
Amid a push to crack down on patent abuse by the pharmaceutical industry, a key…
The XBI comedown after JPM
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Copay coupons for some drugs must count toward deductibles, after Biden court move
WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending…
The big any-day-now biotech news we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: More patients are getting their meds online. Big Pharma wants in on the action
Since the pandemic, patients have become increasingly comfortable with getting their medications online. Direct-to-consumer telehealth…
STAT+: Survey: Confusion over key requirements means clinical trials aren’t registered and results aren’t reported
More than half of those responsible for registering clinical trials and reporting results fail to…